Cline Scientific

Cline Scientific was a Swedish life science company focused on advanced cancer diagnostics, regenerative medicine, and research tools built on patented surface nanotechnology. The company developed nano-structured gradient surfaces intended to control cell behavior and support both cell-based product development and diagnostic applications. Its two main internal programs were StemCART, an allogeneic stem cell therapy approach for cartilage and joint repair, and CellRACE, a cancer diagnostic designed to predict metastatic potential. In addition to therapeutic and diagnostic development, Cline historically sold nanotechnology-based products for stem cell and cancer research. The company was listed on Nasdaq First North Growth Market in Stockholm, but it was declared bankrupt in August 2024 and its shares were subsequently delisted.